• Remdesivir (GS-5734): Polymerase-Led Assay Design

  2026-08-26

  Remdesivir (GS-5734) is examined through a polymerase-centered framework that connects prodrug biology, assay architecture, and emerging zoonotic virus research. The article shows how Nipah virus polymerase structures can improve experimental interpretation without overstating cross-virus efficacy.

• SLC2A5 Fructose Metabolism in PCNSL

  2026-08-26

  A 2026 Advanced Science study uses single-cell RNA and B-cell receptor profiling to connect the glucose-poor, hypoxic primary CNS lymphoma microenvironment with SLC2A5-mediated fructose metabolism. Functional inhibition experiments identify SLC2A5 as a potential metabolic vulnerability in lymphoma cells and tumor-supportive macrophages, while linking the microenvironment to T-cell dysfunction.

• Fucoidan, Irinotecan, and Gut–Liver Axis Injury

  2026-08-25

  This study identifies intestinal barrier disruption and neutrophil extracellular trap formation as connected drivers of CPT-11-induced steatohepatitis. Its findings position fucoidan as a mechanistically focused intervention that preserves gut integrity, limits lipopolysaccharide translocation, and reduces hepatic inflammatory injury, while highlighting important limits for translation beyond the mouse model.

• Safe DNA Gel Stain for Smarter Assays

  2026-08-25

  Safe DNA Gel Stain enables sensitive DNA and RNA gel stain workflows while reducing dependence on ethidium bromide and UV imaging. This guide connects safer nucleic acid visualization with rigorous assay design for mechanistic variant studies and cloning workflows.

• Ac-YVAD-CMK: Causal Assay Design in Inflammation

  2026-08-24

  Ac-YVAD-CMK (N-Ac-Tyr-Val-Ala-Asp-CMK) is used to interrogate caspase-1-dependent inflammation and pyroptosis. This guide develops a causal assay framework for separating membrane repair failure, inflammatory cytokine processing, and Kupffer-cell injury in Listeria models.

• DPPH Antioxidant Screening Workflow

  2026-08-24

  Use DPPH to rank antioxidant capacity rapidly across small molecules, botanical extracts, and cultivation samples. Its plate-compatible color change is especially useful when paired with LC-MS/MS and orthogonal assays to distinguish promising hits from assay artifacts.

• Bestatin (Ubenimex) in Protease Research

  2026-08-23

  Bestatin (Ubenimex) is a selective aminopeptidase probe for connecting enzyme activity with cell behavior, MDR biology, apoptosis assays, and fibrin-based angiogenesis models. APExBIO supplies a research-use reagent suited to workflows that require careful dose selection, orthogonal controls, and matrix-aware interpretation.

• PBS (Phosphate-Buffered Saline): Practical Lab Guide

  2026-08-22

  PBS (Phosphate-Buffered Saline), SKU K2818, provides a sterile, isotonic buffer for routine cell washing, reagent dilution, and compatible in vitro workflows requiring controlled pH. It is for scientific research use only and should not be used for diagnostic, medical, clinical, or in vivo applications.

• Remdesivir (GS-5734): A Polymerase Assay Roadmap

  2026-08-21

  Remdesivir (GS-5734) is examined here through an assay-centered lens, connecting its coronavirus and filovirus activity with new structural insights into the Nipah virus polymerase complex. The article clarifies what polymerase architecture can—and cannot—predict for antiviral research.

• Tamoxifen as a Temporal Control Tool in Biology

  2026-08-20

  Tamoxifen is a selective estrogen receptor modulator with applications extending from breast cancer research to inducible genetics. This article explains how its time-dependent biology can improve causal assay design, using recurrent airway inflammation as a model for experimental reasoning.

• DPPH Antioxidant Screening: From Signal to Strategy

  2026-08-20

  DPPH converts radical-scavenging chemistry into a practical development signal. This thought-leadership guide explains how to use DPPH (2,2-Diphenyl-1-Picrylhydrazyl) Radical in extract profiling, high-throughput screening, and translational decision-making, using new Taihangia rupestris evidence to show why assay context and orthogonal validation matter.

• Actinomycin D: Designing Causal RNA Decay Assays

  2026-08-19

  Actinomycin D and ActD are more than broad transcriptional inhibitors: they are perturbational tools for separating RNA synthesis from post-transcriptional decay. This guide develops an assay-design framework grounded in AML WTAP–m6A research, with practical controls, interpretation strategies, and handling guidance.

• tRF16–ALKBH5 Drives Osteoarthritis Progression

  2026-08-19

  The reference study identifies tRF16 as an overexpressed tRNA-derived fragment that links ALKBH5, NFKBIA mRNA stability, and NF-κB activation in osteoarthritis. Its combined human, animal, and chondrocyte experiments provide a mechanistic framework for understanding how post-transcriptional RNA regulation can promote cartilage degeneration and inflammation.

• circ_0000235, MCT4, and Glycolysis in Bladder Cancer

  2026-08-18

  The reference study identifies circ_0000235 as an upstream regulator of MCT4-driven glycolysis in bladder cancer through sequestration of miR-330-5p. Its integrated molecular, metabolic, cellular, and animal evidence links this competing endogenous RNA axis to tumor growth and migration, while suggesting experimental opportunities for studying transcriptional stress and RNA stability alongside cancer metabolism.

• Trichostatin A (TSA) in Cancer Research

  2026-08-18

  Trichostatin A (TSA) gives researchers a reversible way to connect histone acetylation with differentiation, proliferation, and cell-cycle phenotypes. This practical guide shows how to deploy TSA in cancer research while using mitochondrial calcium and GPX4 findings as a disciplined, hypothesis-generating bridge rather than an assumed mechanism.

7891 records 1/527 page Next 12345 下5页 Last page